Cancer vaccines. Any future? (Q37885282)

24 August 2017

1 reference

title

Cancer vaccines. Any future? (English)

1 reference

24 August 2017

3

Andrzej Myc

1 reference

24 August 2017

2

Andrzej Gamian

1 reference

24 August 2017

Lukasz A Myc

1

1 reference

24 August 2017

publication date

5 June 2011

1 reference

Archivum Immunologiae et Therapiae Experimentalis

24 August 2017

published in

1 reference

24 August 2017

volume

59

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

249-259

1 reference

https://scigraph.springernature.com/pub.10.1007/s00005-011-0129-y

24 August 2017

exact match

0 references

cites work

Squalene and squalane emulsions as adjuvants

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

NK cells negatively regulate antigen presentation and tumor-specific CTLs in a syngeneic lymphoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Cancer immunotherapy: synthetic and natural peptides in the balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

B cells directly tolerize CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Memory CD8+ T cells require CD28 costimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Consequences of the expression of sialylated antigens in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Adjuvants--a classification and review of their modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunostimulation versus immunosuppression after multiple vaccinations: the woes of therapeutic vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Clinical cancer vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Current developments with peptide-based human tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Optimism over vaccines administered via mucosal surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Principles of tumor immunosurveillance and implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immune surveillance: a balance between protumor and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Vaccines against human carcinomas: strategies to improve antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Immunotherapy: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Role of GM-CSF signaling in cell-based tumor immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0129-Y

10.1007/S00005-011-0129-Y

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference